Estrogen, brain structure, and cognition in postmenopausal women. Issue 1 (10th September 2020)

• Record Type: Journal Article
• Authors: Boyle, Christina P.; Raji, Cyrus A.; Erickson, Kirk I.; Lopez, Oscar L.; Becker, James T.; Gach, H. Michael; Kuller, Lewis H.; Longstreth, William; Carmichael, Owen T.; Riedel, Brandalyn C.; Thompson, Paul M.
• Is Part Of: Human brain mapping. Volume 42:Issue 1(2021)
• Page Start: 24
• Page End: 35
• Publication Date: 2020-09-10
• Subjects: Alzheimer's disease -- Brain volume -- hormone therapy; Brain mapping -- Periodicals; 611.81
• DOI: 10.1002/hbm.25200
• Languages: English
• ISSNs: 1065-9471

Abstract

Abstract: Declining estrogen levels before, during, and after menopause can affect memory and risk for Alzheimer's disease. Undesirable side effects of hormone variations emphasize a role for hormone therapy (HT) where possible benefits include a delay in the onset of dementia—yet findings are inconsistent. Effects of HT may be mediated by estrogen receptors found throughout the brain. Effects may also depend on lifestyle factors, timing of use, and genetic risk. We studied the impact of self‐reported HT use on brain volume in 562 elderly women (71–94 years) with mixed cognitive status while adjusting for aforementioned factors. Covariate‐adjusted voxelwise linear regression analyses using a model with 16 predictors showed HT use as positively associated with regional brain volumes, regardless of cognitive status. Examinations of other factors related to menopause, oophorectomy and hysterectomy status independently yielded positive effects on brain volume when added to our model. One interaction term, HTxBMI, out of several examined, revealed significant negative association with overall brain volume, suggesting a greater reduction in brain volume than BMI alone. Our main findings relating HT to regional brain volume were as hypothesized, but some exploratory analyses were not in line with existing hypotheses. Studies suggest lower levels of estrogen resulting from oophorectomy and hysterectomy affect brain volume negatively, and the addition of HT modifies the relation between BMI and brain volume positively. Effects of HT may depend on the age range assessed, motivating studies with a wider age range as well as a randomized design. Abstract : Declining estrogen levels for women in all stages of menopause can affect memory and risk of Alzheimer's Disease (AD), emphasizing a role for hormone therapy (HT). Effects may differ due to several factors including lifestyle and cardiovascular risk, genetic makeup, and timing and duration of HT. We addressed this hypothesis using self‐reported HT in 562 elderly women with mixed cognitive status, covarying for aforementioned factors. Voxelwise regression showed HT use as correlated with higher brain volume regardless of cognitive status